Home > SOP Information > SOPs and Supporting Information – alphabetic listing > H to L > Hepatitis B A010 > Rulebase for hepatitis B > Parenteral drug use

Parenteral drug use

Hepatitis B - Parenteral drug use Factor

Last reviewed for CCPS 23 November 1999.

Investigative Documents

Claimant Report - Parenteral Drug Use - Hepatitis B [CR9051]

Preliminary questions [12017]

[1]10302

the veteran has been a parenteral drug user at some time.

[2]12376

the veteran has been a parenteral drug user and shared needles with a person not shown to be hepatitis B negative at some time.

12375 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative and VEA service for the clinical onset of hepatitis B.

Clinical onset and operational service [12375]

[3]12024

there is evidence of recent infection with the condition under consideration.

[4]12377

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration.

29698 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative and VEA service for recent infection with hepatitis B.

12374 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative on service and operational service for recent infection with hepatitis B.

[5]28731

on operational service, the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration.

[6]28732

the parenteral drug use and sharing of needles on operational service with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration was serious default, a wilful act or a serious breach of discipline.

or

28727 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and operational service for recent infection with hepatitis B.

12373 — the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative as a consequence of an illness or injury which is identifiable. [Default true]

[7]12382

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration as a consequence of an illness or injury which is identifiable.

12378 — the identified illness or injury for which the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative was undertaken is causally related to operational service. [8] [9]

or

28724 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and eligible service for recent infection with hepatitis B.

12379 — the identified illness or injury for which the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative was undertaken is causally related to eligible service. [10] [9]

[11]12380

the veteran has another significant risk factor for the condition under consideration other than parenteral drug use and sharing needles with a person not shown to be hepatitis B negative as a consequence of the identified illness or injury within the six months immediately before the evidence of recent infection with condition under consideration.

or

[12]12025

there is evidence of non-recent infection with the condition under consideration.

[13]28725

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration.

28726 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative and VEA service for non-recent infection with hepatitis B.

28728 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative on service and operational service for non-recent infection with hepatitis B.

[14]28733

on operational service, the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration.

[15]29699

the parenteral drug use and sharing of needles on operational service with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration was serious default, a wilful act or a serious breach of discipline.

or

28730 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and operational service for non-recent infection with hepatitis B.

[7]12381

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration as a consequence of an illness or injury which is identifiable.

or

28729 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and eligible service for non-recent infection with hepatitis B.

[16]29700

the veteran has another significant risk factor for the condition under consideration other than parenteral drug use and sharing needles with a person not shown to be hepatitis B negative as a consequence of the identified illness or injury more than four months before the evidence of non-recent infection with condition under consideration.

Clinical onset and eligible service [12375]

[17]12024

there is evidence of recent infection with the condition under consideration.

[4]12377

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration.

29698 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative and VEA service for recent infection with hepatitis B.

12374 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative on service and operational service for recent infection with hepatitis B.

[5]28731

on operational service, the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration.

[6]28732

the parenteral drug use and sharing of needles on operational service with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration was serious default, a wilful act or a serious breach of discipline.

or

28727 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and operational service for recent infection with hepatitis B.

12373 — the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative as a consequence of an illness or injury which is identifiable. [Default true]

[7]12382

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative within the six months immediately before the evidence of recent infection with the condition under consideration as a consequence of an illness or injury which is identifiable.

12378 — the identified illness or injury for which the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative was undertaken is causally related to operational service. [8] [9]

or

28724 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and eligible service for recent infection with hepatitis B.

12379 — the identified illness or injury for which the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative was undertaken is causally related to eligible service. [10] [9]

[11]12380

the veteran has another significant risk factor for the condition under consideration other than parenteral drug use and sharing needles with a person not shown to be hepatitis B negative as a consequence of the identified illness or injury within the six months immediately before the evidence of recent infection with condition under consideration.

or

[12]12025

there is evidence of non-recent infection with the condition under consideration.

[13]28725

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration.

28726 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative and VEA service for non-recent infection with hepatitis B.

28728 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative on service and operational service for non-recent infection with hepatitis B.

[14]28733

on operational service, the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration.

[15]29699

the parenteral drug use and sharing of needles on operational service with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration was serious default, a wilful act or a serious breach of discipline.

or

28730 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and operational service for non-recent infection with hepatitis B.

[7]12381

the veteran was a parenteral drug user and sharing needles with a person not shown to be hepatitis B negative more than four months before the evidence of non-recent infection with the condition under consideration as a consequence of an illness or injury which is identifiable.

or

28729 — the veteran has established the causal connection between the parenteral drug use and sharing needles with a person not shown to be hepatitis B negative for treatment of an illness or injury and eligible service for non-recent infection with hepatitis B.

[16]29700

the veteran has another significant risk factor for the condition under consideration other than parenteral drug use and sharing needles with a person not shown to be hepatitis B negative as a consequence of the identified illness or injury more than four months before the evidence of non-recent infection with condition under consideration. [17]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-b-a010-b16b180b181/rulebase-hepatitis-b/parenteral-drug-use

Links
[1] https://clik.dva.gov.au/ccpsclaimant-227
[2] clikpopup://CCPS/reject10302No
[3] clikpopup://CCPS/reject12376No
[4] clikpopup://CCPS/reject12024No
[5] clikpopup://CCPS/reject12377No
[6] clikpopup://CCPS/reject28731No
[7] clikpopup://CCPS/rejectwilful
[8] clikpopup://CCPS/reject12382No
[9] clikpopup://CCPS/reject12378,12379No
[10] clikpopup://CCPS/reject12379No
[11] clikpopup://CCPS/Another significant risk factor other than parenteral drug use and sharing needles 6 months before recent infection with hepatitis B due to ill/inj
[12] clikpopup://CCPS/reject12380Yes
[13] clikpopup://CCPS/reject12025No
[14] clikpopup://CCPS/reject28725No
[15] clikpopup://CCPS/reject28733No
[16] clikpopup://CCPS/reject12381No
[17] clikpopup://CCPS/reject29700Yes